title: [Controlled prospective study of chemotherapy in advanced ovarian cancer--cyclophosphamide monochemotherapy versus polychemotherapy with adriamycin, cyclophosphamide, 5-fluorouracil and methotrexate].
authors.forename: V
authors.initials: V
authors.lastname: Chylak
authors.forename: K
authors.initials: K
authors.lastname: Kolarić
authors.forename: J
authors.initials: J
authors.lastname: Krusić
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use*; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000473:pathology; D011446:Prospective Studies
chemical_list: D004317:Doxorubicin; D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate
vernacular_title: Kontrolirana prospektivna studija kemoterapije uznapredovalog raka jajnika--monokemoterapija ciklofosfamidom prema polikemoterapiji adriamicinom, ciklofosfamidom, 5-fluorouracilom i metotreksatom.